- Home
- LYB vs VTR Comparison
LYB vs VTR Comparison
Compare LYB & VTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYB
- VTR
- Stock Information
- Founded
- LYB 1955
- VTR 1983
- Country
- LYB United States
- VTR United States
- Employees
- LYB N/A
- VTR N/A
- Industry
- LYB Major Chemicals
- VTR Real Estate Investment Trusts
- Sector
- LYB Industrials
- VTR Real Estate
- Exchange
- LYB Nasdaq
- VTR Nasdaq
- Market Cap
- LYB 24.9B
- VTR 25.0B
- IPO Year
- LYB N/A
- VTR 1998
- Fundamental
- Price
- LYB $76.97
- VTR $66.10
- Analyst Decision
- LYB Hold
- VTR Buy
- Analyst Count
- LYB 13
- VTR 9
- Target Price
- LYB $88.25
- VTR $64.33
- AVG Volume (30 Days)
- LYB 2.6M
- VTR 2.6M
- Earning Date
- LYB 01-31-2025
- VTR 02-12-2025
- Dividend Yield
- LYB 6.96%
- VTR 2.91%
- EPS Growth
- LYB N/A
- VTR N/A
- EPS
- LYB 4.15
- VTR 0.19
- Revenue
- LYB $40,302,000,000.00
- VTR $4,889,015,000.00
- Revenue This Year
- LYB N/A
- VTR N/A
- Revenue Next Year
- LYB $4.20
- VTR $7.69
- P/E Ratio
- LYB $18.60
- VTR $358.75
- Revenue Growth
- LYB N/A
- VTR 9.46
- 52 Week Low
- LYB $72.21
- VTR $41.45
- 52 Week High
- LYB $107.02
- VTR $67.61
- Technical
- Relative Strength Index (RSI)
- LYB 50.69
- VTR 67.51
- Support Level
- LYB $76.56
- VTR $58.72
- Resistance Level
- LYB $78.15
- VTR $67.38
- Average True Range (ATR)
- LYB 1.48
- VTR 1.40
- MACD
- LYB 0.06
- VTR 0.66
- Stochastic Oscillator
- LYB 64.91
- VTR 83.86
About LYB LyondellBasell Industries NV (Netherlands)
LyondellBasell is a petrochemical producer with operations in the United States, Europe, and Asia. The company is the world's largest producer of polypropylene and is also a major producer of polyethylene and propylene oxide. Its chemicals are used in various consumer and industrial end products. Well over half of LyondellBasell's production comes from its North American operations.
About VTR Ventas Inc.
Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.